 |
|
|
|
|
|
NEWS RELEASE:
FOR IMMEDIATE RELEASE:
|
|
|
MERGE HEALTHCARE ANNOUNCES NEW CONTRACTS FOR RECENTLY
RELEASED FUSION RIS/PACS MX™ SOLUTION
Milwaukee, WI, June 5, 2007 – Merge Healthcare (NASDAQ: MRGE; TSX: MRG), a leading medical imaging software and services provider, today announced several new contracts for Fusion RIS/PACS MX, a complete workflow solution for clinical and business imaging workflow, released in April 2007. The new contracts include:
- Atlanta Radiology Consultants, Atlanta, GA: This radiology group practice provides outside reads for specialty practices and VA medical centers. The business is making a significant move, as it shifts from Merge Healthcare’s digital workstation to leverage the integrated imaging informatics value of Fusion RIS/PACS MX.
- Center for Medical Imaging, Germantown, WI: This freestanding diagnostic imaging center will use Fusion RIS/PACS MX to streamline operational efficiency, specifically in tracking exams and billing.
- Zwanger-Presiri Radiology, Long Island, NY: With 25 physicians in eight locations across two counties, this group of eight imaging centers will upgrade from existing Merge Healthcare technology to Fusion RIS/PACS MX to improve clinical performance and achieve new workflow efficiencies.
These contracts affirm the rapid acceptance of the Fusion RIS/PACS MX solution. With a positive ROI for an imaging business and a uniquely optimized radiologist workspace, Fusion RIS/PACS MX provides a comprehensive solution for imaging centers, small hospitals and specialty clinics in the United States.
“Customers value Merge Healthcare’s long-standing and proven history in delivering solutions that are relevant to the needs of imaging operations,” said Gary Bowers, President for Merge Healthcare North America. “Our RIS and PACS solutions are in hundreds of organizations serving millions of patients annually. We are proud to work collaboratively with customers to continue to explore new ways for technology to help improve both clinical and financial success.”
Merge Healthcare research identifies a compelling market need for PACS and RIS technologies – especially among hospitals with fewer than 200 beds. These facilities, which represent nearly 70% of all U.S. acute care hospitals and freestanding imaging centers, have grown in number from 4,000 to 6,000 in the last five years.
# # #
Merge Healthcare is a market leader in the development and delivery of medical imaging and information management software and services. Our innovative software solutions use leading-edge imaging software technologies that accelerate market delivery for our OEM customers, while our end-user solutions improve our customers' productivity and enhance the quality of patient care they provide. For additional information, visit our website at www.mergehealthcare.com.
All trademarks appearing in this release are the property of Cedara Software Corp. and/or Merge Healthcare.
|
Attn: Beth Frost-Johnson
Merge Healthcare
6737 West Washington St.
Suite 2250
Milwaukee, WI 53214
|
|
|
|
|
|
| Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.
|
|
|
